Founded in 1919
Olympus Corporation announced the consolidated results for the second quarter of FY 2027, reporting revenue of 269.2 billion yen, a 9% increase year-over-year. Adjusted operating margin was 17.8%, and adjusted EPS was 32 yen, up 38% year-over-year. Additionally, the company raised its full-year outlook for FY 2027.
On October 7, 2026, Olympus received a Warning Letter from the U.S. Food and Drug Administration and outlined its approach to addressing the issues related to its quality management system. The CEO pledged swift and thorough corrective actions, while the CQO emphasized ongoing quality improvement.
The Olympus Museum will be temporarily closed on Thursday, September 24, and Friday, September 25, 2026, to prepare the exhibition environment. We apologize for the inconvenience and appreciate your understanding.
Olympus Corporation's global headquarters (located in Hachioji City, Tokyo) was established in April 2024 through the integration of business functions. By adopting open offices and labs, and promoting collaboration across departments, the company was awarded the 'New Office Promotion Award' at the 39th Nikkei New Office Award, hosted by the New Office Promotion Association and the Nihon Keizai Shimbun. The award was recognized as part of a corporate culture reform that enables employees to perform at their best.
Olympus will launch the LTF-S700-10-3D, a curved insertion video scope supporting 4K, 3D, and infrared observation, in Japan and Europe in September 2026. The product is designed to meet diverse observation needs and improve the efficiency and quality of endoscopic surgery.
Olympus signed a global sales agreement with Canada's Endocision and will begin selling its portable cryobiopsy system. The product is planned for launch in the United States, Canada, and Europe in early 2027 and is designed for use in a range of clinical settings.
Olympus announced consolidated first-quarter revenue of ¥240.4 billion for the fiscal year ending March 2027, up 16% year on year. Growth in its Gastrointestinal Endotherapy Solutions business drove overall performance, and margins improved. Its Surgical Intervention business was affected by a shipment suspension, while Urology and Respiratory businesses achieved revenue growth.
The Olympus Group donated 10 million yen through the Japanese Red Cross Society to support victims of the 8th year of Reiwa Kumamoto Earthquake. Additionally, they provided disaster relief supplies and conducted employee donations to support the recovery of the affected areas.
The Olympus Museum will be closed for summer from August 10 to 14, 2026, and will reopen as usual from August 17.
Olympus completes the new B building at its Nagano plant, enhancing production and development of medical device components.